Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators.
OBJECTIVE
To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators.


METHODS
Capture-recapture techniques with covariate effects.


METHODS
Liverpool, Brighton, and 12 London boroughs, 2000/01.


METHODS
IDU collated and matched across five data sources-community recruited survey, specialist drug treatment, arrest referral, syringe exchange, and accident and emergency-896 in Brighton, 1224 in Liverpool, and 6111 in London.


RESULTS
It is estimated that in 2000/01 the number and prevalence of IDU aged 15-44 was 2300 (95%CI 1500 to 3700) and 2.0% (95%CI% 1.3% to 3.2%) in Brighton; 2900 (95%CI 2500 to 5000) and 1.5% (95%CI 1.3% to 2.6%) in Liverpool; 16 700 (95%CI 13 800 to 21 600) and 1.2% (95%CI 1.0% to 1.6%) in 12 London boroughs; with a prevalence of 1.7% (95%CI 1.2% to 3.3%) in inner London. It is estimated that: less than one in four IDU are in treatment in the three areas; syringe exchange programmes covered about 25% of injections in Brighton and Liverpool and 20% in London; and that the annual opioid mortality rate among IDU was 2% in Brighton compared with less than 1% in Liverpool and London.


CONCLUSIONS
Credible estimates of the prevalence of injecting drug use (and key public health indicators) can be determined using covariate capture-recapture techniques. These suggest that: targets to double the number in treatment are possible: syringe distribution should be increased; and further attention, especially in Brighton, given to reducing overdose mortality.
Hickman
Matthew
M
CRDHB, Social Science and Medicine, Imperial College, Charing Cross Campus, St Dunstans Road, London SW6 1RQ, UK. m.hickman@imperial.ac.uk
Higgins
Vanessa
V
Hope
Vivian
V
Bellis
Mark
M
Tilling
Kate
K
Walker
Angeline
A
Henry
John
J
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D004739:England / Q000453:epidemiology; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008131:London / Q000453:epidemiology; D008297:Male; D018671:Needle-Exchange Programs / Q000600:supply & distribution; D015995:Prevalence; D011634:Public Health / Q000706:statistics & numerical data*; D017678:Sex Distribution; D015819:Substance Abuse, Intravenous / Q000453:epidemiology* / Q000628:therapy; D014504:Urban Health / Q000706:statistics & numerical data